These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1316058)
1. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study. Grassi C; Albera C; Pozzi E Am J Med; 1992 Apr; 92(4A):103S-107S. PubMed ID: 1316058 [TBL] [Abstract][Full Text] [Related]
2. A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology. Kemper P; Köhler D Am J Med; 1992 Apr; 92(4A):98S-102S. PubMed ID: 1316079 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis. Gotfried MH; Ellison WT Am J Med; 1992 Apr; 92(4A):108S-113S. PubMed ID: 1316059 [TBL] [Abstract][Full Text] [Related]
4. Infection in the elderly: studies with lomefloxacin. Crome P; Bruce-Jones P Am J Med; 1992 Apr; 92(4A):126S-129S. PubMed ID: 1316062 [TBL] [Abstract][Full Text] [Related]
5. Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis. Klietmann W; Cesana M; Rondel RK; Focht J Antimicrob Agents Chemother; 1993 Nov; 37(11):2298-306. PubMed ID: 8285609 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the safety and efficacy of lomefloxacin and amoxicillin in the treatment of acute exacerbations of chronic bronchitis: Results from a Latin American multicenter study. Saenz-Aguirre C; Amaya-Tapia G; Andrade-Villanueva J; Perez-Gomez R; Morfin-Otero R; Rodriguez-Noriega E Int J Antimicrob Agents; 1992 Dec; 2(1):49-54. PubMed ID: 18611519 [TBL] [Abstract][Full Text] [Related]
7. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: results of multinational studies. Yernault JC; Russell D Int J Antimicrob Agents; 1992 Dec; 2(1):39-47. PubMed ID: 18611518 [TBL] [Abstract][Full Text] [Related]
8. Safety and effectiveness of lomefloxacin in patients with acute exacerbation of chronic bronchitis (AECB) chronically treated with oral theophyllines. Melani AS; Pirrelli M; Sarlo F; Cantoni V; J Chemother; 2001 Dec; 13(6):628-34. PubMed ID: 11806624 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis. DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434 [TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis. Langan CE; Cranfield R; Breisch S; Pettit R J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875 [TBL] [Abstract][Full Text] [Related]
11. Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group. O'Doherty B; Daniel R Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):441-6. PubMed ID: 9758290 [TBL] [Abstract][Full Text] [Related]
12. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin. Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620 [TBL] [Abstract][Full Text] [Related]
13. The U.S. clinical experience with lomefloxacin, a new once-daily fluoroquinolone. Rizk E Am J Med; 1992 Apr; 92(4A):130S-135S. PubMed ID: 1316063 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily. Chodosh S; Lakshminarayan S; Swarz H; Breisch S Antimicrob Agents Chemother; 1998 Jan; 42(1):114-20. PubMed ID: 9449270 [TBL] [Abstract][Full Text] [Related]
15. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group. DeAbate CA; Henry D; Bensch G; Jubran A; Chodosh S; Harper L; Tipping D; Talbot GH Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458 [TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis. DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487 [TBL] [Abstract][Full Text] [Related]
17. A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritis. Mouton Y; Ajana F; Chidiac C; Capron MH; Home P; Masquelier AM Am J Med; 1992 Apr; 92(4A):87S-90S. PubMed ID: 1316078 [TBL] [Abstract][Full Text] [Related]
18. Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study group. File T; Schlemmer B; Garau J; Lode H; Lynch S; Young C J Chemother; 2000 Aug; 12(4):314-25. PubMed ID: 10949981 [TBL] [Abstract][Full Text] [Related]
19. Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study. Pisani E; Bartoletti R; Trinchieri A; Rizzo M J Chemother; 1996 Jun; 8(3):210-3. PubMed ID: 8808718 [TBL] [Abstract][Full Text] [Related]
20. Use of quinolones for the treatment of acute exacerbations of chronic bronchitis. Chodosh S Am J Med; 1991 Dec; 91(6A):93S-100S. PubMed ID: 1662900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]